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Dietary saturated fat and fibre and risk of cardiovascular disease and all-
cause mortality among type 1 diabetic patients: The EURODIAB
Prospective Complications Study
Abstract
Aims/hypothesis: Low adherence to recommendations for dietary saturated fatty acid (SFA) and fibre intake in
patients with type 1 diabetes mellitus may heighten their increased risk of cardiovascular disease (CVD) and
mortality. We examined the relationship of SFA and total, soluble and insoluble fibre with incident CVD and
all-cause mortality in type 1 diabetic patients.
Methods: A prospective cohort analysis was performed in 2,108 European type 1 diabetic patients aged 15-60
years who were free of CVD at baseline and enrolled in the EURODIAB Prospective Complications Study
(51% male). Diet was assessed from a standardised 3 day dietary record. HR were calculated using Cox
proportional hazards models.
Results: During a mean follow-up of 7.3 years, 148 incident cases of fatal and non-fatal CVD and 46 all-cause
deaths were documented. No statistically significant association was found between SFA and CVD and all-
cause mortality. Total dietary fibre, per 5 g/day, was associated with lower all-cause mortality risk (HR
0.72;95% CI 0.55, 0.95). This association was stronger for soluble fibre (per 5 g/day, HR 0.34;95% CI 0.14,
0.80) compared with insoluble fibre (per 5 g/day; HR 0.66;95% CI 0.45, 0.97). Similar results were found for
the association with CVD.
Conclusions/interpretation: This study suggests that reported dietary SFA is not significantly associated with
CVD and allcause mortality in type 1 diabetic patients. On the contrary, higher dietary fibre consumption,
especially soluble fibre, within the range commonly consumed by type 1 diabetic patients, may contribute to
the prevention of CVD and allcause mortality in type 1 diabetic patients.
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Abstract
Aims/hypothesis Low adherence to recommendations for
dietary saturated fatty acid (SFA) and fibre intake in patients
with type 1 diabetes mellitus may heighten their increased
risk of cardiovascular disease (CVD) and mortality. We
examined the relationship of SFA and total, soluble and
insoluble fibre with incident CVD and all-cause mortality
in type 1 diabetic patients.
Methods A prospective cohort analysis was performed in
2,108 European type 1 diabetic patients aged 15–60 years
who were free of CVD at baseline and enrolled in the
EURODIAB Prospective Complications Study (51% male).
Diet was assessed from a standardised 3 day dietary record.
HR were calculated using Cox proportional hazards models.
Results During a mean follow-up of 7.3 years, 148 incident
cases of fatal and non-fatal CVD and 46 all-cause deaths
were documented. No statistically significant association
was found between SFA and CVD and all-cause mortality.
Total dietary fibre, per 5 g/day, was associated with lower
all-cause mortality risk (HR 0.72; 95% CI 0.55, 0.95). This
association was stronger for soluble fibre (per 5 g/day, HR
0.34; 95% CI 0.14, 0.80) compared with insoluble fibre (per
5 g/day; HR 0.66; 95% CI 0.45, 0.97). Similar results were
found for the association with CVD.
Conclusions/interpretation This study suggests that reported
dietary SFA is not significantly associated with CVD and all-
cause mortality in type 1 diabetic patients. On the contrary,
higher dietary fibre consumption, especially soluble fibre,
within the range commonly consumed by type 1 diabetic
patients, may contribute to the prevention of CVD and all-
cause mortality in type 1 diabetic patients.
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Introduction
Patients with type 1 diabetes mellitus are at a markedly
increased risk of cardiovascular disease (CVD) [1, 2]. The
most important modifiable risk factors for CVD, hypercho-
lesterolaemia and hypertension, are more common in dia-
betic patients than in the general population [3, 4]. Diet is an
important modifiable factor that is related to CVD risk
factors [5, 6]. A focus of dietary recommendations for both
CVD and diabetes prevention and treatment has been a
reduction in saturated fatty acid (SFA) intake and an in-
crease in dietary fibre intake [7, 8]. However, low adherence
to dietary recommendations (<10% of energy intake from
SFA and 20 g/1,000 kcal for dietary fibre) [9], and even less
healthy eating habits compared with a non-diabetic popula-
tion [10], may heighten the increased risk of CVD in
patients with type 1 diabetes [11]. Both nutrients are impor-
tant, as it has been shown that low SFA intake is often
accompanied by high dietary fibre intake and a healthy
lifestyle [12], which might affect the association with
CVD risk, as suggested from cross-sectional studies [13,
14]. In type 1 diabetic patients an independent association
has been shown between dietary fibre intake and serum
cholesterol (in men) and CVD (in women) [14].
A recent systematic review [15] and meta-analysis [16]
found that there was no statistically significant evidence of
an association between SFA intake and CVD risk in the
general population, even though several weaknesses in the
meta-analysis may question the validity of the results [17,
18]. Besides, neither the systemic review nor the meta-
analysis separately evaluated whether intake of SFA may
have a different association with CVD risk depending on the
nutrient being replaced. Evaluation of the association be-
tween SFA intake and CVD, however, requires replacement
by other macronutrients to maintain energy balance.
The importance of adequate dietary fibre intake in the
prevention and treatment of CVD is well established in the
general population. Results from a pooled analysis of cohort
studies [19] and a review [20] suggest an inverse association
between dietary fibre intake and coronary heart disease risk
in the general population. In the Nurses’ Health Study,
reduced all-cause and CVD-specific mortality was found
in type 2 diabetic patients with higher wholegrain and bran
intakes [21]. No intervention trials have explored the effect
of dietary fibre intake on CVD or all-cause mortality risk.
Little information on nutritional intake is available from
large cohorts of type 1 diabetic patients sufficiently fol-
lowed up for CVD and deaths. Possible relationships with
dietary SFA and fibre have not yet been established in this
population. Therefore the aim of the present study was to
investigate the relationship between dietary SFA and total,
soluble and insoluble fibre and incident CVD and all-cause
mortality in patients with type 1 diabetes.
Methods
Study design The EURODIAB Prospective Complications
Study (PCS) is a clinic-based prospective cohort study in-
cluding 3,250 individuals with type 1 diabetes. Participants
were recruited from 31 centres in 16 European countries and
examined between 1989 and 1991. The prevalence of
diabetic complications was measured and risk factors asso-
ciated with these complications were explored. Each centre
selected a random sample of patients stratified by sex, age
and diabetes duration. Details on patient selection and the
standardised methodology have been published elsewhere
[22, 23]. Type 1 diabetes was defined as diabetes diagnosed
before the age of 36 years with a continuous need for insulin
within 1 year of diagnosis. Of those invited, 85% participated.
Pregnant women and those with a diabetes duration of less
than 1 year were excluded. Ethics committee approval con-
forming to the Declaration of Helsinki was obtained at each
centre; all participants provided written informed consent.
Study population Seven years after the baseline examina-
tion, study participants were invited for re-examination. Of
the 3,250 participants at baseline, 1,142 were excluded for
the following reasons: no participation in follow-up exami-
nation (n0464), known CVD at baseline (n0238), no infor-
mation on SFA and dietary fibre at baseline (n0247), and no
information on CVD at follow-up (n0193), leaving 2,108
participants available for analysis.
Assessment of nutrients Dietary nutrients were determined
at baseline (1989–1991) from a standardised 3 day dietary
record [24]. Dietary records comprising 2 workdays and
1 day free of work (Saturday or Sunday) were completed
by participants according to instructions from a local dieti-
tian. These records were coded by a dietitian using a cen-
trally prepared EURODIAB food list and finally rechecked
and computed at the Nutrition Coordinating Centre in
Düsseldorf. Pilot study checks were conducted to establish
how well we could approximate the intake of 7 days of the
week with a 3 day dietary record. No differences were found
in the proportion of nutrients between the days. Total energy
was calculated using Atwater factors [25]. The nutrients fat
(total fat, SFA, monounsaturated fatty acids [MUFA] and
polyunsaturated fatty acids [PUFA]), dietary fibre (total,
soluble and insoluble fibre), carbohydrates (CH), protein,
alcohol and total energy (including energy derived from
alcohol consumption) were calculated using the EURO-
DIAB nutrient database [26]. The program could not pro-
vide quantities of trans-fatty acids (TFA), as complete
information on the consumed foods was not available.
A representative sample of the total EURODIAB cohort
was randomly selected to test repeatability of the nutritional
data [24]. Patients were asked to fill in a second 3 day
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dietary record 3 weeks after completing the first 3 day
record. Repeatability was measured by comparing mean
differences with SD for protein, fat (including SFA), CH,
dietary fibre, alcohol and energy from the first and second
3 day dietary record. Mean differences in nutrients from the
first and second 3 day dietary record were 0.5 g (SD 12.7;
95% CI −1.2, 2.2) for SFA and −0.2 g (SD 5.5; 95% CI −0.9,
0.5) for dietary fibre. A high degree of repeatability was
demonstrated and plausible energy values were recorded by
90% of the patients, thus supporting its validity.
Assessment of fatal and non-fatal CVD and all-cause
mortality Presence of CVD at follow-up was defined as a
positive medical history of a cardiovascular event including
myocardial infarction, angina pectoris, coronary artery by-
pass graft surgery or stroke, and/or by electrocardiograms
suggestive of probable or possible ischaemia determined
from centrally Minnesota-coded electrocardiograms [27].
All CVD events were captured by questionnaires with ad-
ditional supporting information from hospital records, death
certificates and other healthcare documents. Data on mor-
tality were collected at follow-up from hospital case notes or
other sources of clinical data at every participating centre.
Information on the cause of death was reported by the
physician or extracted from hospital records when death
certificates could not be obtained. Causes of death were
coded according to the ICD-9 (www.icd9data.com/2007/
Volume1/240-279/250-259/250/default.htm).
Assessment of potential confounders Triacylglycerol and
total and HDL-cholesterol were determined using fasting
serum and standard enzymatic methods (Boehringer
Mannheim, Lewes, UK). LDL-cholesterol was calculated
using the Friedewald equation [28]. HbA1c was measured
by enzyme immunoassay using a monoclonal antibody (The
Royal London Hospital, London, and Dako, Ely, UK).
HbA1c values obtained were converted to Diabetes Control
and Complications Trial (DCCT; %) [29] and International
Federation of Clinical Chemistry and Laboratory Medicine
(IFCC; mmol/mol) values in line with the recommendations
of the European Association for the Study of Diabetes
(EASD) [30]. Resting blood pressure was measured twice
with a random zero sphygmomanometer (Hawksley,
Lancing, UK). Information on diabetes duration, daily insu-
lin dose and frequency, physical activity and smoking status
was gathered from a general questionnaire on lifestyle,
disease history and family history completed by all partic-
ipants. Alcohol was assessed from the 3 day dietary record.
Weight and height were measured with indoor clothing
without shoes, and BMI was calculated.
Statistical analysis All descriptive data were expressed as
mean±SD or median and interquartile range (IQR). The
nutrient residual method by Willett was used to adjust
nutrients for total energy [31]. Energy-adjusted nutrients
are computed as the residuals from the regression model,
with total energy as an independent variable and the abso-
lute nutrient as a dependent variable. The nutrient residuals
provide a measure of nutrient intake uncorrelated with total
energy intake [31]. For descriptive purposes, the nutrient
densities (energy percentage [en%]) were calculated as a ratio
of nutrient content (g/day) to total energy content (in kJ).
To examine associations between baseline SFA and die-
tary fibre (total, soluble and insoluble) and incident fatal and
non-fatal CVD and all-cause mortality we used Cox pro-
portional hazards analyses to estimate HR and 95% CI.
Survival time for each participant was defined as the time
between the date of study entry and the occurrence of a
CVD event, death, loss to follow-up, or the end of the study,
whichever came first. SFA and dietary fibre were energy-
adjusted by the residual method and divided into tertiles,
with the lowest category as the reference group, to explore
different nutrient values and trends. To retain power, SFA
and dietary fibre were also analysed as continuous variables.
We used three models to adjust for confounders. In model 1,
estimates were adjusted for age, sex and energy (kJ/day). In
model 2, diabetes duration (years), HbA1c (%), smoking
status (number of non-smokers, previous or current smok-
ers), physical activity (physical inactivity, mild physical
activity ≥1 time/week, moderate physical activity ≥1 time/
week, vigorous physical activity ≥1 time/week) and alco-
hol (0, >0–<5, 5–<15, 15–<30, 30–<40 and ≥40 g/day)
were added. In model 3, adjustments for total dietary fibre
(g/1,000 kcal) for the relationships of SFAwith CVD and all-
cause mortality, or SFA (en%) for the relationships of dietary
fibre with CVD and all-cause mortality, were added. To show
the robustness of our results, final adjustments were made for
MUFA and PUFA (g/day), antihypertensive use (yes or no),
daily insulin dose (units/kg) and frequency (number of injec-
tions per day). Finally, potential mediators such as systolic
blood pressure, total/HDL-cholesterol ratio and BMI were
explored to demonstrate potential pathways.
We carried out replacement models [32] to investigate
whether a 5% higher energy intake from MUFA, PUFA or
CH should replace a 5% lower energy intake from SFA to
prevent CVD. Two models were used. Model 1 included
age, sex, MUFA, PUFA, TFA, CH and protein expressed as
percentages of total energy, and total energy (kJ/day). TFA
was calculated as the difference between total fat and major
groups of fatty acids (SFA, MUFA and PUFA), as exact
values for TFA were not available. Model 2 included vari-
ables in model 1 and confounders similar to those of model 2
as described above. The estimated HR for MUFA or PUFA
and CH can be interpreted as the estimated difference in risk
of a 5% lower energy intake from SFA and a concomitant
higher energy intake from MUFA, PUFA or CH.
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Possible effect modification by age was tested and a
p value for interaction <0.10 was considered statistically
significant. Including an interaction term to identify
modification by centre was not possible, since we had
31 centres in this study in 16 European countries with
unequal numbers of participants per centre or country.
We did not have a sufficient number of cases for strat-
ified analyses. Data analysis was performed using SAS
software (version 9.1; SAS Institute, Cary, NC, USA).
Two-sided p values <0.05 were considered statistically
significant.
Results
Study characteristics Electronic supplementary material
(ESM) Table 1 shows a comparison of CVD risk factors
between participants excluded from the present study and
participants remaining for analyses. Excluded participants
appeared to have higher SFA and lower dietary fibre con-
sumption, but a higher CVD risk profile with increased age,
diabetes duration, HbA1c, systolic blood pressure, BMI,
total/HDL-cholesterol ratio, physical activity and smoking.
During a median follow-up period of 7.4 years (IQR 6.9–
7.8 years), 148 fatal and non-fatal CVD incident cases and
46 all-cause deaths occurred among 2,108 participants (51%
male). Among men and women at baseline, the median age
was 31 years (IQR 25–38), the median diabetes duration
was 13 years (IQR 7–19), the median SFA intake was 13.5
en% (IQR 11.4–16.1) and the median total dietary fibre
intake was 8.2 g/1,000 kcal (IQR 6.0–10.7). Median intakes
were 5.7 g/day (IQR 4.3–7.3) for soluble fibre and 12.4 g/
day (IQR 9.4–15.9) for insoluble fibre.
Risk factors for CVD according to baseline SFA are given
in ESM Table 2. SFA was positively associated with being
female, diabetes duration, smoking, alcohol and moderate
physical activity, and negatively associated with dietary fibre.
Risk factors for CVD according to baseline total dietary
fibre are given in Table 1. Participants in the highest tertile
for dietary fibre were more likely to be female, more phys-
ically active, smoked less and had lower values for alcohol
compared with participants in the lowest tertile. On the other
hand, an increase in use of antihypertensive medication was
seen over tertiles of total dietary fibre.
SFA and CVD risk HR and 95% CI for fatal and non-fatal
CVD according to tertiles of SFA and per 10 g/day are
shown in Table 2. No statistically significant association
between SFA and CVD was found, with or without adjust-
ment for potential confounders. The association between
replacement of 5% of energy from SFA by concomitant
higher energy from MUFA, PUFA or CH and CVD risk
was also not statistically significant (Table 3).
SFA and all-cause mortality risk No statistically significant
association between all-cause mortality and SFA was found
(HR 0.70; 95% CI 0.48, 1.04) with multivariate adjustment,
per 10 g/day SFA (data not shown).
Dietary fibre and CVD risk HR and 95% CI for fatal and
non-fatal CVD are shown in Table 4. A significantly re-
duced CVD risk of 16% was found per 5 g/day total dietary
fibre (95% CI 0.72, 0.98). For soluble fibre, a significantly
decreased CVD risk of 44% (95% CI 0.35, 0.90; p for trend,
0.01) was found in the highest tertile, 39% (95% CI 0.38,
0.97) for each 5 g/day and 20% (95% CI 0.67, 0.97) for each
2 g/day. Additional adjustment for MUFA (g/day) and
PUFA (g/day), antihypertensive use (yes or no) and daily
insulin dose (units per kg) and frequency (no. of injections
per day) did not alter these associations (highest tertile, HR
0.58; 95% CI 0.33, 0.93; per 5 g/day, HR 0.64; 95% CI
0.35, 0.98; per 2 g/day, HR 0.82; 95% CI 0.65, 0.98). For
insoluble fibre, a significantly decreased CVD risk of 24%
was found per 5 g/day (95% CI 0.61, 0.94). Adjustments for
potential mediators such as systolic blood pressure, total/
HDL-cholesterol ratio and BMI did not alter any of the
above-mentioned associations with CVD risk and we could
not identify any clear pathway (ESM Table 3).
Dietary fibre and all-cause mortality risk A significant in-
verse association was found after adjustment for potential
confounders including age, sex, energy intake, diabetes
duration, HbA1c, smoking status, physical activity, alcohol
and SFA for the relationship between dietary fibre and all-
cause mortality. A significantly decreased all-cause mortal-
ity risk of 28% was found for each 5 g/day total dietary fibre
(95% CI 0.55, 0.95; Table 5). The association with all-cause
mortality was stronger for soluble fibre (HR 0.34; 95% CI
0.14, 0.80) than for insoluble fibre (HR 0.66; 95% CI
0.45, 0.97; Table 5). These associations became stronger
after additional adjustments for MUFA (g/day) and PUFA
(g/day), antihypertensive use (yes or no), and daily insu-
lin dose (units/kg) and frequency (no. of injections per
day; soluble fibre, HR 0.28; 95% CI 0.11, 0.68; insoluble
fibre, HR 0.60; 95% CI 0.40, 0.90). A significantly
decreased all-cause mortality risk of 37% was found per
2 g/day soluble fibre (95% CI 0.45, 0.87). Adjustments
for potential mediators such as systolic blood pressure,
total/HDL-cholesterol ratio and BMI did not alter any of
the above-mentioned associations with all-cause mortality
risk (ESM Table 4).
Discussion
The results of the present study among 2,108 European
patients with type 1 diabetes suggest an inverse association
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between dietary fibre and CVD risk and all-cause mor-
tality, with a stronger protective association for soluble
fibre compared with insoluble fibre. No statistically
significant association was found between all-cause
mortality risk and SFA and CVD, nor between all-
cause mortality risk and replacing 5% of energy from
SFA by concomitant higher energy from PUFA, MUFA
or CH.
The present findings on SFA support the results of
previous studies in the general population [15, 16] demon-
strating that there is no statistically significant relationship
between SFA and CVD risk. However, a cross-sectional
study performed among children and adolescents with type
1 diabetes showed that a diet high in energy from SFA was
associated with a higher risk of CVD [11]. A recent meta-
analysis of randomised controlled trials [33] and a pooled
Table 1 Baseline characteristics of type 1 diabetic patients in the EURODIAB PCS according to tertiles of dietary fibre intake (n02,108)
Characteristic Tertiles of fibre intakea p value
for trend
1 2 3
n 702 703 703
Mean follow-up, years 7.3±0.9 7.3±1.1 7.2±1.0 0.03
Age, years 31.0±9.1 32.3±9.8 32.9±10.1 0.0003
Sex, n (%) male 393 (65.0) 330 (46.9) 358 (50.9) 0.06
Diabetes duration, years 13.1 (7.8–18.7) 13.0 (7.3–19.7) 12.8 (6.7–20.3) 0.41
HbA1c, % (mmol/mol) 8.3±2.0 (67.2) 8.0±1.8 (63.9) 8.0±1.9 (63.9) 0.003
Daily insulin dose, units/kg 0.7 (0.6–0.8) 0.7 (0.5–0.8) 0.6 (0.5–0.8) 0.002
Daily insulin frequency, injections/day 2.0 (2.0–3.0) 3.0 (2.0–3.0) 3.0 (2.0–3.0) 0.03
Systolic blood pressure, mmHg 119.1±16.4 120.2±16.8 120.8±17.1 0.06
Diastolic blood pressure, mmHg 75.1±11.2 75.0±11.2 75.1±11.2 0.9
Antihypertensive use, n (%) 42 (6.0) 54 (7.8) 63 (9.0) 0.03
BMI, kg/m2 23.6±2.8 23.4±2.6 23.4±2.9 0.16
Triacylglycerol, mmol/l 0.9 (0.7–1.3) 0.9 (0.7–1.3) 0.8 (0.7–1.1) 0.02
Total cholesterol, mmol/l 5.4±1.1 5.3±1.1 5.3±1.2 0.05
HDL-cholesterol, mmol/l 1.5±0.4 1.5±0.4 1.5±0.4 0.51
LDL-cholesterol, mmol/l 3.4±1.0 3.3±1.0 3.3±1.0 0.15
Total/HDL-cholesterol ratio, mmol/l 3.4±1.4 3.4±1.1 3.4±1.2 0.28
Physical inactivity, n (%) 15 (2.2) 18 (2.6) 27 (3.9) <0.0001
Mild physical activity ≥1 time/week, n (%) 230 (33.2) 241 (34.7) 195 (28.2) <0.0001
Moderate physical activity ≥1 time/week, n (%) 237 (34.3) 214 (30.8) 241 (34.8) 0.24
Vigorous physical activity ≥1 time/week, n (%) 210 (30.4) 222 (31.9) 229 (33.1) <0.0001
Ever-smoker, n (%) 382 (54.4) 332 (47.2) 304 (43.2) <0.0001
Alcohol intake, g/day 2.4 (0.0–13.0) 1.0 (0.0–8.8) 0.0 (0.0–5.3) <0.0001
None, n (%) 293 (41.7) 338 (48.1) 392 (55.8) <0.0001
≤20 g/day, n (%) 290 (41.3) 275 (39.1) 264 (37.6) <0.0001
>20 g/day, n (%) 119 (17.0) 90 (12.8) 47 (6.7) <0.0001
Total energy intake, kJ/day 9,824.3 (8,177.4–12,170.6) 9,279.0 (7,722.2–11,155.8) 9,905.0 (8,254.4–11,951.4) 0.84
Total fat, g/daya 106.1 (93.8–118.5) 98.3 (88.2–108.9) 98.8 (79.7–100.2) <0.0001
SFA, g/daya 40.2 (34.8–46.4) 37.0 (32.2–42.6) 32.3 (27.6–38.2) <0.0001
SFA, en% 15.1 (12.9–17.4) 13.8 (11.7–16.3) 12.1 (10.0–14.2) <0.0001
MUFA, g/daya 40.8 (35.3–48.2) 38.6 (33.6–45.7) 34.7 (29.5–41.8) <0.0001
PUFA, g/daya 14.7 (11.3–19.8) 14.5 (11.3–18.8) 14.0 (10.5–18.6) 0.004
Total fibre, g/daya 13.4 (11.3–14.7) 18.6 (17.2–19.8) 25.2 (22.8–28.3) <0.0001
Total fibre, g/1000 kcal 5.6 (4.9–6.2) 7.9 (7.3–8.4) 10.7 (9.8–12.2) <0.0001
Soluble fibre, g/daya 4.2 (3.5–4.7) 5.8 (5.3–6.4) 7.9 (7.1–9.2) <0.0001
Insoluble fibre, g/daya 8.9 (7.6–9.9) 12.5 (11.7–13.5) 17.3 (15.6–19.5) <0.0001
Values are mean±SD, median (IQR) or n (%)
a Nutrient intakes were adjusted for total energy intake by using the nutrient residual method [31]
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analysis of 11 cohort studies [34] both found consistent
evidence in the general population of decreased CVD
risk when SFA was replaced by PUFA. In contrast with
these studies, we did not find any association with CVD
risk when SFA was replaced by MUFA, PUFA or CH,
which might be explained by a lack of power in our
study.
Our results on dietary fibre confirm the results of a cross-
sectional study among type 1 diabetic patients which
showed that a diet low in fibre, fruit and vegetables could
lead to a higher risk of CVD [11]. Also, results from cohort
studies in the general population suggesting an inverse
association between dietary fibre and CVD risk are in line
with our results [19, 20]. We found a significantly lower
CVD risk of 32% per 10 g/day total dietary fibre (95% CI
0.48, 0.95), which is in accordance with the pooled analyses
of cohort studies in the general population by Pereira et al.
[19]. Such a change in total dietary fibre is challenging to
achieve; however, a more realistic change in dietary fibre of
5 g/day was significantly associated with a 16% lower risk
in our study (95% CI 0.72, 0.98). Some studies on whether
protection of dietary fibre may come from soluble and/or
insoluble fibre show no clear advantage of either type of
dietary fibre [35, 36], whereas the pooled analysis of Pereira
et al. shows a stronger inverse association for soluble fibre
[19]. These authors showed a lower coronary heart disease
risk of 44% per 10 g/day, whereas we found in type 1
diabetic patients a lower CVD risk of 67% per 10 g/day
soluble fibre (95% CI 0.13, 0.88). Again, 10 g/day soluble
fibre may be unfeasible; however, changing this to 2 g/day
soluble fibre showed a statistically significantly lower CVD
risk of 18% in our study (95% CI 0.67, 0.97). Besides the
inverse association between dietary fibre and CVD risk, we
observed a significant inverse association with all-cause
mortality, which is in line with results found in the general
population [37], as well as in patients with type 2 diabetes
Table 2 HR for fatal and non-fatal CVD and SFA in participants in the EURODIAB PCS (n02,108)
Variable Tertiles of SFA p value for trend Per 10 g/day SFA
1 2 3
Median SFA, g/day (IQR) 28.6 (24.8–31.0) 36.6 (34.9–38.5) 45.4 (42.7–49.5) 34.8 (25.7–45.5)
n 702 703 703 2,108
n cases 52 48 48 148
Person-years 5,101 5,090 5,118 15,309
Model 1a 1.00 1.04 (0.70, 1.57) 1.00 (0.67, 1.48) 0.99 0.95 (0.79, 1.13)
Model 2b 1.00 1.07 (0.70, 1.62) 1.03 (0.68, 1.55) 0.91 0.96 (0.80, 1.18)
Model 3c 1.00 0.95 (0.62, 1.46) 0.84 (0.53, 1.32) 0.43 0.85 (0.69, 1.05)
Values are HR (95% CI) obtained from Cox proportional hazards models according to stratification by tertiles of SFA and continuously
per 10 g/day SFA. SFA was adjusted for total energy using the nutrient residual method [31]
aModel 1 adjusted for age (continuous), sex and energy (kJ/day)
bModel 2 additionally adjusted for diabetes duration (years), HbA1c (%), smoking status (no, previous, current), physical activity (physical
inactivity, mild physical activity ≥1 time/week, moderate physical activity ≥1 time/week, vigorous physical activity ≥1 time/week) and
alcohol (0, >0–<5, 5–<15, 15–<30, 30–<40, ≥40 g/day)
cModel 3 additionally adjusted for total dietary fibre (g/1,000 kcal)
Table 3 HR for replacing 5% of energy from MUFA, PUFA or CH
by 5% of energy from SFA and fatal and non-fatal CVD risk in
participants in the EURODIAB PCS (n02,108, n cases0148)
Model HR 95% CI
MUFA for SFA
Model 1a 1.00 0.98, 1.02
Model 2b 0.98 0.89, 1.07
PUFA for SFA
Model 1a 1.00 0.94, 1.07
Model 2b 0.99 0.89, 1.09
CH for SFA
Model 1a 0.98 0.94, 1.02
Model 2b 0.96 0.89, 1.05
Values are HR and 95% CI obtained from Cox proportional hazards
models. The estimated HR for MUFA, PUFA or CH can be interpreted
as replacing 5% of energy from MUFA, PUFA or CH by 5% of energy
from SFA and occurrence of CVD
Nutrients were adjusted for total energy by using the nutrient residual
method [31]
aModel 1 included age (continuous), sex, MUFA, PUFA, TFA, protein
and CH (en%), and total energy (kJ/day)
bModel 2 additionally included diabetes duration (years), HbA1c (%),
smoking status (no, previous, current), physical activity (physical
inactivity, mild physical activity ≥1 time/week, moderate physical
activity ≥1 time/week, vigorous physical activity ≥1 time/week) and
alcohol (0, >0–<5, 5–<15, 15–<30, 30–<40, ≥40 g/day)
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[21]. In the Nurses’ Health Study [21], bran intake in the
highest quintile was associated with a 28% (95% CI 0.56,
0.92) lower all-cause mortality risk and a 35% (95% CI
0.43, 0.99) lower CVD-specific mortality risk in type 2
diabetic patients. In the Zutphen Study [37], no clear differ-
ence between the effects of dietary fibre from various sour-
ces was observed. Park et al. [38] showed in a non-diabetic
population a significant inverse association with all-cause
mortality from total dietary fibre and grains, but not from
other sources, whereas we showed significant inverse asso-
ciations in type 1 diabetic patients for total, soluble and
insoluble fibre. Most likely, as assessed in prospective
studies, dietary fibre within the usual diet is a marker of
healthy food choices with an overall cardiovascular bene-
fit [19]. However, in our study, we were able to demon-
strate an independent protective association between
dietary fibre and CVD risk in type 1 diabetic patients,
after adjustment for lifestyle factors characterising a healthy
lifestyle.
The present study is, to our knowledge, the first large
prospective cohort study with a sufficient number of CVD
cases and deaths in young type 1 diabetic patients to report
the associations between SFA and dietary fibre and risk of
CVD and all-cause mortality in this population. The ob-
served relationships were independent of sex, age, energy
intake, CVD risk factors and other dietary factors. The
strength of the study lies in its large sample size of European
type 1 diabetic patients. Furthermore, the EURODIAB PCS
provides a multicentre, clinic-based, prospective study, with
the same standardised methods used in each centre. How-
ever, some limitations should be addressed. First, the accu-
racy of dietary data and the absence of data on foods are
important limitations. The use of information on dietary
intake from self-reported 3 day dietary records may be
Table 4 HR for fatal and non-fatal CVD according to total, soluble and insoluble fibre intake in participants in the EURODIAB PCS (n02,108)
Intake Tertiles of fibre intake p value for trend Per 2 g/day Per 5 g/day
1 2 3
n 702 703 703
Total fibre
Median intake g/day (IQR) 13.4 (11.3–14.7) 18.6 (17.2–19.8) 25.2 (22.8–28.3)
n cases 50 60 38
Person-years 5,141 5,102 5,066
Model 1a 1.00 1.12 (0.77, 1.64) 0.69 (0.45, 1.06) 0.08 0.94 (0.89, 0.99) 0.86 (0.75, 0.98)
Model 2b 1.00 1.15 (0.81, 1.72) 0.74 (0.47, 1.14) 0.11 0.94 (0.89, 1.00) 0.87 (0.76, 0.99)
Model 3c 1.00 1.09 (0.78, 1.70) 0.69 (0.43, 1.11) 0.05 0.93 (0.87, 0.98) 0.84 (0.72, 0.98)
Soluble fibre
Median intake g/day (IQR) 4.1 (3.5–4.6) 5.8 (5.4–6.3) 7.9 (7.2–9.2)
n cases 55 56 37
Person-years 5,149 5,073 5,087
Model 1a 1.00 0.97 (0.67, 1.42) 0.61 (0.40, 0.93) 0.02 0.84 (0.72, 0.99) 0.66 (0.44, 0.98)
Model 2b 1.00 1.02 (0.69, 1.51) 0.63 (0.41, 0.98) 0.03 0.85 (0.72, 1.01) 0.69 (0.45, 1.06)
Model 3c 1.00 0.98 (0.66, 1.45) 0.56 (0.35, 0.90) 0.01 0.80 (0.67, 0.97) 0.61 (0.38, 0.97)
Insoluble fibre
Median intake g/day (IQR) 8.9 (7.6–9.9) 12.5 (11.7–13.5) 17.3 (15.6–19.5)
n cases 48 57 43
Person-years 5,144 5,103 5,062
Model 1a 1.00 1.08 (0.73, 1.60) 0.80 (0.53, 1.22) 0.26 0.92 (0.85, 0.99) 0.80 (0.66, 0.97)
Model 2b 1.00 1.09 (0.74, 1.62) 0.83 (0.54, 1.27) 0.34 0.92 (0.85, 0.99) 0.81 (0.67, 0.99)
Model 3c 1.00 1.05 (0.71, 1.57) 0.76 (0.48, 1.21) 0.21 0.89 (0.81, 0.97) 0.76 (0.61, 0.94)
Values are HR (95% CI) obtained from Cox proportional hazards models according to stratification by tertiles of total, soluble and insoluble fibre
intake and continuously per 2 g/day and 5 g/day increase in total, soluble and insoluble fibre intake. Fibre intake was adjusted for total energy intake
by using the nutrient residual method [31]
aModel 1 adjusted for age (continuous), sex and energy intake (kJ/day)
bModel 2 additionally adjusted for diabetes duration (years), HbA1c (%), smoking status (no, previous, current), physical activity (physical
inactivity, mild physical activity ≥1 time/week, moderate physical activity ≥1 time/week, vigorous physical activity ≥1 time/week) and alcohol
intake (0, >0–<5, 5–<15, 15–<30, 30–<40, ≥40 g/day)
cModel 3 additionally adjusted for SFA intake (en%)
2138 Diabetologia (2012) 55:2132–2141
subject to the weakness of the nutritional data [26]. Mea-
surement error is always an inherent limitation in self-
reported dietary assessment and has an impact on results,
conclusions and interpretation. Under the assumption that
measurement error is non-differential with regard to the
outcome, this might have led to biased risk estimates and
reduced statistical power for detecting associations. Second,
1,142 participants were excluded from the present study due
to loss to follow-up and missing information on dietary
intake, potential confounders, and CVD and/or all-cause
mortality at follow-up. Loss to follow-up due to no partic-
ipation at follow-up and no information on CVD and/or all-
cause mortality at follow-up might have caused a selection
bias which could have modified the associations under
study. We compared those included in the study with those
lost to follow-up and found that patients with a more ath-
erosclerotic risk profile were lost, which may imply that our
demonstrated associations for dietary fibre and CVD or all-
cause mortality could have been even stronger if these
patients had been included. Furthermore, although we mini-
mised the influence of confounding in the associations by
adjustment for key confounders, residual confounding can-
not be ruled out due to interference by factors we did not
measure. Finally, upon diagnosis many patients might have
received dietary advice from dietitians and physicians at
diabetes clinics which might have introduced bias in our
results. However, this study gives insight into the real-life
course of the disease.
Possible reasons for not finding any association between
SFA and blood cholesterol and CVD could be inaccurate
dietary methods; large day-to-day variations; chain length of
SFA, animal or plant source; natural or interesterified forms
of SFA [39]. Replacement of SFA by PUFA has indeed been
shown to be effective in reducing CVD risk in both meta-
analyses of prospective studies [34] and in controlled feed-
ing trials [33]; therefore recommendations should remain
unaltered with the advice to restrict SFA intake below 7%
of total energy intake, particularly in patients at increased
risk of CVD.
Several mechanisms have been suggested by which die-
tary fibre may reduce CVD risk in the general population.
Several studies have found that increased dietary fibre may
lower the risk of type 2 diabetes [40–42], which may partly
explain our associations with CVD and all-cause mortality
[21]. Including potential mediators such as systolic blood
pressure, serum cholesterol and BMI did not lead to identi-
fication of a clear pathway. Soluble fibre might be able to
delay the absorption of nutrients and bind bile acids in the
small intestine, which may increase bile acid excretion [43].
These effects have been shown to lower total and LDL-
cholesterol levels [44] and improve insulin sensitivity [45].
This in turn is associated with reductions in blood pressure
[46]. In addition, soluble fibre-containing foods such as fruit
and vegetables have been shown to slow down or reduce
glucose absorption in the intestine due to a reduction in the
glycaemic index [47, 48]. Results from the EURODIAB
PCS show that total dietary fibre was significantly inversely
associated with HbA1c levels, independently of other life-
style and nutritional factors [49].
In conclusion, our results in European individuals with
type 1 diabetes do not show a statistically significant asso-
ciation between SFA and CVD risk. By contrast, higher
total, soluble and insoluble dietary fibre appears to be
strongly protective of CVD and all-cause mortality in our
population. These results are in line with the current dietary
guidelines for diabetic patients on dietary fibre-rich foods
[9, 50]: to encourage dietary fibre intake from wholegrains,
fruit, vegetables and various sources that are easily available
and not too costly in the different European countries. Trials
of dietary intervention in type 1 diabetes should focus on
acceptable methods to increase dietary fibre intake, and
determine the effects on CVD and all-cause mortality risk.
Moreover, considering limitations of dietary assessment
methods, we recommend further research by other studies
and designs investigating the role of dietary SFA and fibre
and the risk of CVD and all-cause mortality in type 1
diabetic patients.
Table 5 HR for all-cause mortality according to each increase in
2 g/day and 5 g/day total, soluble and insoluble fibre intake in
participants in the EURODIAB PCS (n02,108, n cases046)
Intake Per 2 g/day Per 5 g/day
Total fibre
Model 1a 0.93 (0.85, 1.02) 0.84 (0.67, 1.06)
Model 2b 0.92 (0.83, 1.01) 0.83 (0.65, 1.05)
Model 3c 0.87 (0.78, 0.97) 0.72 (0.55, 0.95)
Soluble fibre
Model 1a 0.78 (0.58, 1.04) 0.53 (0.26, 1.11)
Model 2b 0.73 (0.54, 1.00) 0.51 (0.24, 1.10)
Model 3c 0.63 (0.45, 0.87) 0.34 (0.14, 0.80)
Insoluble fibre
Model 1a 0.92 (0.81, 1.05) 0.81 (0.58, 1.12)
Model 2b 0.90 (0.79, 1.03) 0.79 (0.57, 1.11)
Model 3c 0.84 (0.72, 0.97) 0.66 (0.45, 0.97)
Values are HR and 95% CI obtained from Cox proportional hazards
models according to each 2 g/day and 5 g/day increase in total, soluble
and insoluble fibre. Fibre intake was adjusted for total energy intake
(kJ/day) using the nutrient residual method [31]
aModel 1 adjusted for age (continuous), sex and energy (kJ/day)
bModel 2 additionally adjusted for diabetes duration (years), HbA1c
(%), smoking status (no, previous, current), physical activity (physical
inactivity, mild physical activity ≥1 time/week, moderate physical
activity ≥1 time/week, vigorous physical activity ≥1 time/week) and
alcohol intake (0, >0–<5, 5–<15, 15–<30, 30–<40, ≥40 g/day)
cModel 3 additionally adjusted for SFA intake (en%)
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